Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Dyadic International, Inc.    DYAI

DYADIC INTERNATIONAL, INC.

(DYAI)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/23/2020 11/24/2020 11/25/2020 11/27/2020 11/30/2020 Date
5.98(c) 5.77(c) 5.69(c) 5.78(c) 5.86(c) Last
173 732 375 225 154 153 84 905 140 418 Volume
-7.57% -3.51% -1.39% +1.58% +1.38% Change
More quotes
Financials (USD)
Sales 2020 1,83 M - -
Net income 2020 -9,39 M - -
Net Debt 2020 - - -
P/E ratio 2020 -17,0x
Yield 2020 -
Sales 2021 2,43 M - -
Net income 2021 -9,41 M - -
Net Debt 2021 - - -
P/E ratio 2021 -18,0x
Yield 2021 -
Capitalization 161 M 161 M -
Capi. / Sales 2020 87,9x
Capi. / Sales 2021 66,4x
Nbr of Employees 6
Free-Float 48,4%
More Financials
Company
Dyadic International, Inc. is a global biotechnology company. The Company is focused on developing and licensing the C1 platform for use in human and animal pharmaceutical applications across the world. The Company has developed a method for producing commercial quantities of enzymes and other proteins, which it uses to develop and produce some of its own industrial enzymes, as well as licensing this technology to... 
More about the company
Notations Surperformance© of Dyadic International, Inc.
Trading Rating : - Investor Rating :
More Ratings
All news about DYADIC INTERNATIONAL, INC.
11/12DYADIC INTERNATIONAL : Announces Third Quarter 2020 Financial Results and Highli..
PU
11/12DYADIC INTERNATIONAL : Management's Discussion and Analysis of Financial Conditi..
AQ
11/12DYADIC INTERNATIONAL INC : Results of Operations and Financial Condition, Financ..
AQ
10/29DYADIC INTERNATIONAL : to Report Third Quarter 2020 Financial Results on Thursda..
PU
10/13DYADIC INTERNATIONAL INC : Other Events, Financial Statements and Exhibits (form..
AQ
09/17DYADIC INTERNATIONAL, INC. : Dyadic Announces Collaboration with Jiangsu Hengrui..
EQ
09/14DYADIC INTERNATIONAL : to Present at Upcoming Investor and Industry Events
PU
08/13DYADIC INTERNATIONAL : Announces Second Quarter 2020 Results and Highlights Rece..
PU
08/13DYADIC INTERNATIONAL INC : Results of Operations and Financial Condition, Financ..
AQ
08/13DYADIC INTERNATIONAL : Management's Discussion and Analysis of Financial Conditi..
AQ
07/30DYADIC INTERNATIONAL : to Report Second Quarter 2020 Financial Results on Thursd..
PU
07/01DYADIC INTERNATIONAL INC : Submission of Matters to a Vote of Security Holders (..
AQ
06/29DYADIC INTERNATIONAL INC : Entry into a Material Definitive Agreement, Financial..
AQ
05/14DYADIC INTERNATIONAL : Management's Discussion and Analysis of Financial Conditi..
AQ
05/14DYADIC INTERNATIONAL INC : Results of Operations and Financial Condition, Financ..
AQ
More news
News in other languages on DYADIC INTERNATIONAL, INC.

- No features available -

More news
Chart DYADIC INTERNATIONAL, INC.
Duration : Period :
Dyadic International, Inc. Technical Analysis Chart | DYAI | US26745T1016 | MarketScreener
Technical analysis trends DYADIC INTERNATIONAL, INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 2
Average target price 10,50 $
Last Close Price 5,86 $
Spread / Highest target 87,7%
Spread / Average Target 79,2%
Spread / Lowest Target 70,6%
EPS Revisions
Managers
NameTitle
Mark A. Emalfarb President, Chief Executive Officer & Director
Michael P. Tarnok Chairman
Ping W. Rawson Chief Financial Officer
Ronen Tchelet Vice President-Research & Business Development
Seth J. Herbst Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
DYADIC INTERNATIONAL, INC.11.58%159
MODERNA, INC.549.44%50 267
LONZA GROUP AG56.23%45 319
CELLTRION, INC.82.04%40 460
IQVIA HOLDINGS INC.9.26%32 365
SEAGEN INC.48.01%30 493